|
1
|
Afewerki S, Bassous N, Harb S, Palo-Nieto C, Ruiz-Esparza GU, Marciano FR, Webster TJ, Furtado ASA, Lobo AO. Advances in dual functional antimicrobial and osteoinductive biomaterials for orthopaedic applications. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2019; 24:102143. [PMID: 31862427 DOI: 10.1016/j.nano.2019.102143] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2019] [Revised: 12/02/2019] [Accepted: 12/04/2019] [Indexed: 12/15/2022]
Abstract
A vast growing problem in orthopaedic medicine is the increase of clinical cases with antibiotic resistant pathogenic microbes, which is predicted to cause higher mortality than all cancers combined by 2050. Bone infectious diseases limit the healing ability of tissues and increase the risk of future injuries due to pathologic tissue remodelling. The traditional treatment for bone infections has several drawbacks and limitations, such as lengthy antibiotic treatment, extensive surgical interventions, and removal of orthopaedic implants and/or prosthesis, all of these resulting in long-term rehabilitation. This is a huge burden to the public health system resulting in increased healthcare costs. Current technologies e.g. co-delivery systems, where antibacterial and osteoinductive agents are delivered encounter challenges such as site-specific delivery, sustained and prolonged release, and biocompatibility. In this review, these aspects are highlighted to promote the invention of the next generation biomaterials to prevent and/or treat bone infections and promote tissue regeneration.
Collapse
Affiliation(s)
- Samson Afewerki
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham & Women´s Hospital, Cambridge, MA, USA; Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, MIT, Cambridge, MA, USA.
| | - Nicole Bassous
- Nanomedicine Laboratory, Department of Chemical Engineering, Northeastern University, Boston, MA, USA
| | - Samarah Harb
- Institute of Chemistry, São Paulo State University, Araraquara, - SP, Brazil
| | - Carlos Palo-Nieto
- Department of Medicinal Chemistry, BMC, Uppsala University, Uppsala, Sweden
| | - Guillermo U Ruiz-Esparza
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham & Women´s Hospital, Cambridge, MA, USA; Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, MIT, Cambridge, MA, USA
| | - Fernanda R Marciano
- Department of Physics, UFPI- Federal University of Piauí, Teresina, PI, Brazil
| | - Thomas J Webster
- Nanomedicine Laboratory, Department of Chemical Engineering, Northeastern University, Boston, MA, USA
| | - André Sales Aguiar Furtado
- LIMAV - Interdisciplinary Laboratory for Advanced Materials, Department of Materials Engineering, UFPI- Federal University of Piauí, Teresina, PI, Brazil
| | - Anderson O Lobo
- LIMAV - Interdisciplinary Laboratory for Advanced Materials, Department of Materials Engineering, UFPI- Federal University of Piauí, Teresina, PI, Brazil; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
| |
Collapse
|